跳至主要内容
临床试验/CTRI/2018/04/013523
CTRI/2018/04/013523招募中2 期

A prospective open labeled randomized clinical trial on VATHA PITHTHAM primary systemic hypertension with evaluation of trial drug SENKALUNEER CHOORANAM

Prof Dr S Neelavathi1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2017年6月27日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
40
试验地点
1
主要终点
To Evaluate the Therapeutic Efficacy of KALUNEER CHOORANAM in the Treatment of VATHA PITHTHAM

研究概览

简要总结

The Study is Prospective Open Labeled Randomized Phase II Clinical Trial to Evaluate the Therapeutic Efficacy of Trail Drug SENKALUNEER CHOORANAM 800mg 1000mg tds for 30 days on the 40 Patients with VATHA PITHTHAM that will be conducted in Government Siddha Medical College and Hospital Palayamkottai The Primary Out come Therapeutic efficacy of SENKALUNEER CHOORANAM The Sencondary will be the Evaluation of Siddha Diagnostic Parameters

研究设计

研究类型
Observational

入排标准

年龄范围
30.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patient with Symtoms Headache Giddiness Palpitation Dizziness Dyspnoea Shortness of Breath Fatigue Blood Pressure Systolic
  • 159 mmHg Diastolic 90.

排除标准

  • Secondary Hypertension High Risk Pregnancy Hypertension Associated Cerebro Vascular Accident Ischemic Heart Disease Chronic Alcoholism Chronic Liver Disease Chronic Renal Disease Endocrine Disorder.

结局指标

主要结局

To Evaluate the Therapeutic Efficacy of KALUNEER CHOORANAM in the Treatment of VATHA PITHTHAM

时间窗: 30 Days

次要结局

  • To Evaluate the Siddha Cofactor Towords the Efficacy of the Trial Drug SENKALUNEER CHOORANAM and to Evaluate the Pharmacological Action(30 Days)

研究者

发起方
Prof Dr S Neelavathi
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验